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Abstract

The quaternary structure and dynamics of the human small heat-shock protein Hsp27 are linked to its
molecular chaperone function and influenced by post-translational modifications, including phosphorylation.
Phosphorylation of Hsp27 promotes oligomer dissociation and can enhance chaperone activity. This study
explored the impact of phosphorylation on the quaternary structure and dynamics of Hsp27. Using mutations
that mimic phosphorylation, and ion mobility mass spectrometry, we show that successive substitutions result
in an increase in the conformational heterogeneity of Hsp27 dimers. In contrast, we did not detect any
changes in the structure of an Hsp27 12-mer, representative of larger Hsp27 oligomers. Our data suggest that
oligomer dissociation and increased flexibility of the dimer contribute to the enhanced chaperone activity of
phosphorylated Hsp27. Thus, post-translational modifications such as phosphorylation play a crucial role in
modulating both the tertiary and quaternary structure of Hsp27, which is pivotal to its function as a key
component of the proteostasis network in cells. Our data demonstrate the utility of ion mobility mass
spectrometry for probing the structure and dynamics of heterogeneous proteins.
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Abstract
The quaternary structure and dynamics of the human small heat-shock protein Hsp27 are
linked to its molecular chaperone function and influenced by post-translational
modifications, including phosphorylation. Phosphorylation of Hsp27 promotes oligomer
dissociation and can enhance chaperone activity. This study explored the impact of
phosphorylation on the quaternary structure and dynamics of Hsp27. Using mutations that
mimic phosphorylation, and ion mobility mass spectrometry we show that successive
substitutions result in an increase in the conformational heterogeneity of Hsp27 dimers. In
contrast, we did not detect any changes in the structure of an Hsp27 12mer, representative
of larger Hsp27 oligomers. Our data suggests that oligomer dissociation and increased
flexibility of the dimer contribute to the enhanced chaperone activity of phosphorylated
Hsp27. Thus, post-translational modifications such as phosphorylation play a crucial role in
modulating both the tertiary and quaternary structure of Hsp27, which is pivotal to its
function as a key component of the proteostasis network in cells. Our data demonstrates
the utility of ion mobility mass spectrometry for probing the structure and dynamics of
heterogeneous proteins.
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Introduction
Hsp27 (HSPB1) is a mammalian small heat-shock protein (sHsp) that is constitutively
expressed in muscle, neuronal and cancer cells1,2. Hsp27 forms large polydisperse
oligomers3,4 and the amount of Hsp27 in cells increases dramatically during periods of cell
stress5. Through its roles in preventing protein aggregation3,6-9, stabilising the
cytoskeleton10,11 and inhibiting apoptosis12,13, Hsp27 plays a key role in maintaining protein
homeostasis (proteostasis) in cells. Moreover, mutations in Hsp27 are associated with
diseases such as Charcot-Marie Tooth disease and distal hereditary motor neuropathies14-16.
It is generally accepted that the quaternary structure and dynamics of sHsps are linked to
their molecular chaperone function17-20. However, little focus has been placed on the
quaternary structure and dynamics of Hsp27, despite its role in a range of cellular functions.
In addition, Hsp27 undergoes stress-induced phosphorylation at three serine residues (S15,
S78 and S82) in its N-terminal region, which regulates its assembly and chaperone
function21,22. Moreover, the oligomeric state of Hsp27 is modulated by both concentration
and post-translational modifications23,24. Our previous work investigated the effect of
phosphorylation on the structure and function of Hsp27 using mutations that mimic
phosphorylation (MMP). We demonstrated that the dissociation of oligomers and
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chaperone activity was enhanced with an increasing number of MMPs23. As a result, we
proposed that the dimer is the chaperone-active unit of Hsp27, however, it was unclear
whether the dissociation of oligomers into dimers (i.e. changes in quaternary structure) or
phosphorylation-induced changes in the conformation and/or dynamics of the dimer itself
(i.e. changes in tertiary structure), or both, are responsible for the enhanced chaperone
activity of phosphorylated Hsp27. Moreover, there has been little work conducted to date
exploring the structural dynamics of Hsp27 at the tertiary and quaternary level.
Native mass spectrometry (MS) offers great potential for the study of multimeric protein
assemblies, and has been successfully used to study the quaternary organisation of various
sHsps, including Hsp276,23,25-28. Native MS allows the interrogation of the structure and
dynamics of individual species present in a complex mixture, which cannot be achieved with
standard biophysical approaches that average over all species in solution. Here we
capitalised on the capabilities of IM-MS to explore the impact phosphorylation has on the
tertiary and quaternary structure and dynamics of Hsp27. To investigate the effect of
phosphorylation, isoforms of Hsp27 with MMP (Hsp27M) were examined by IM-MS to
ascertain the conformational state of two oligomeric forms, dimers and 12mers, the latter
as a representative of large oligomers formed by Hsp27. In addition, the unfolding dynamics
of Hsp27 dimers were examined via collision-induced unfolding (CIU) in order to observe
any differences in the unfolding of dimers with MMP. Our data are consistent with
phosphorylation regulating the conformational heterogeneity and stability of Hsp27 dimers.
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Experimental Section
Protein Expression and Purification. The gene encoding human Hsp27 (HSPB1; UniProt
accession number P04792) was expressed in E. coli BL21(DE3) using a plasmid kindly gifted
by Drs. W. C. Boelens and W. W. de Jong (University of Nijmegen, The Netherlands), in
which HSPB1 was cloned into the BamHI and NdeI restriction sites of pET3a (Novagen). The
Hsp27 phosphomimic-encoding plasmids (S15D, S15/82D and S15/78/82D) were generated
by site-directed mutagenesis of the wild-type-containing plasmid by GenScript (Piscataway,
NJ, USA). Expression and purification of each recombinant protein was performed as
described previously6,29.
Analytical-SEC. The oligomeric size of Hsp27-WT and Hsp27M was determined by analyticalSEC. Samples (50 µM) were loaded onto a Superdex 200 10/300 GL analytical size-exclusion
column (GE Healthcare), which had been equilibrated in 200 mM ammonium acetate
(NH4OAc) (pH 6.8), at a flow rate of 0.4 mL/min at room temperature. The size-exclusion
columns were calibrated using standards (Bio-Rad): bovine thyroglobulin (670 kDa), bovine
γ-globulin (158 kDa), chicken ovalbumin (44 kDa) and horse myoglobin (17 kDa).
Intrinsic tryptophan fluorescence. Intrinsic tryptophan fluorescence was used to examine
changes in the tertiary and quaternary structure of Hsp27 (Hsp27 contains the following
tryptophan residues; W16, W22, W42, W45, W51 and W95). Tryptophan fluorescence
spectra were attained using a Cary Eclipse fluorescence spectrophotometer (Varian, USA).
Proteins were prepared to a final concentration of 50 µM in 200 mM NH4OAc (pH 6.8).
Proteins were incubated at room temperature for 15 min prior to tryptophan fluorescence
analysis. The excitation wavelength was set at 295 nm and 350 nm and emission wavelength
was recorded from 300-400 nm. Slit widths for excitation and emission spectra were both
set at 5 nm.
Bulk-FRET monitoring of subunit exchange. Bulk-FRET was used to determine whether
Hsp27-WT and Hsp27-3D were capable of subunit exchange. Hsp27-WT was labelled with
CF-488A (Sigma-Aldrich) and CF-647 succinimidyl ester dyes (Biotium) and Hsp27-3D was
labelled with CF-488A (Sigma-Aldrich) succinimidyl ester dye. Individual stocks of labelled
proteins were made up to 25 µM in 50 mM phosphate buffer (pH 7.4). Samples were
equilibrated by incubation at 37°C for 1 h and placed on ice for 20 min to halt subunit
5

exchange30. Subunit exchange was monitored using a POLARstar plate reader (BMG Lab
Technologies) based on the change in FRET over time. Equimolar ratios of the putative
subunit-exchange pairs (i.e. Hsp27-WT-488 + Hsp27-3D-647; Hsp27-WT-488 + Hsp27-WT647) were plated (in duplicate) into a black 384-microwell plate and FRET monitored for 90
min at 37°C by measuring the levels of fluorescence with a 490/650 nm excitation/emission
filter set. The ratio of fluorescence intensity at any point in time, F(t), to fluorescence
intensity at time zero, F(0), was calculated, i.e. F(t)/F(0). An increase in this fluorescence
ratio was indicative of subunit exchange. Subsequent reaction curves were fitted with a onephase association (exponential) curve to determine the subunit-exchange rate constant (k).
Subunit exchange was also confirmed by analytical-SEC whereby samples were taken
directly from the 384-well microplates and loaded onto a Superdex 200 10/300 GL
analytical-SEC pre-equilibrated with 50 mM phosphate buffer (pH 7.4) with multiwavelength detection set at 280, 495 and 650 nm and eluted at 0.3 mL/min.
Ion mobility mass spectrometry. IM-MS was performed on a Synapt G1 HDMS (Waters)
using a nanoelectrospray ionisation source following a previously described protocol31. Prior
to all MS analyses, Hsp27-WT and Hsp27M were buffer-exchanged using a Superdex 200
10/300 GL analytical size-exclusion column (GE Healthcare), which had been equilibrated in
200 mM NH4OAc (pH 6.8), at a flow rate of 0.4 mL/min at room temperature. Protein
concentration was adjusted to 50 µM for IM-MS experiments and 2 µL of protein was
loaded into gold-coated borosilicate glass capillaries prepared in-house. To investigate the
quaternary architecture of Hsp27 assemblies, gentle source conditions were required to
minimise gas-phase compaction and unfolding prior to detection. Key instrument
parameters were as follows: capillary voltage (kV): 1.60-1.65; sampling cone (V): 40;
extraction cone (V): 2.0; trap/transfer collision energy (V): 15/10; trap gas (L/hr): 6.0;
backing gas (mbar): ~6.5. The parameters for the IM were as follows: IM cell wave height
(V): 8-10; IM cell wave velocity (m/s): 300; transfer t-wave height (V): 8; transfer t-wave
velocity (m/s): 200.
The IM data for the large oligomer (12mer) were acquired as described previously32,33. Key
instrument parameters were as follows: capillary voltage (kV): 1.60-1.65; sampling cone (V):
40; extraction cone (V): 2.0; trap/transfer collision energy (V): 15/10; trap gas (L/hr): 6.0;
backing gas (mbar): ~6.5. IM parameters were as follows: IM cell wave height (V): 10-14.5;
6

IM cell wave velocity (m/s): 300; transfer wave height (V): 8; transfer wave velocity (m/s):
200. Arrival time distributions (ATDs) were acquired and calculated using Driftscope 2.1
(Waters) as described previously32.
Collision-induced unfolding (CIU). To investigate the CIU dynamics of Hsp27 dimers, given
that all the single phosphomimic isoforms were structurally and functionally similar (as were
all the double phosphomimic isoforms)23, the S15D, S15/82D and S15/78/82D mutants were
selected as representatives of the 1D, 2D and 3D isoforms respectively (referred to
hereafter as Hsp27-1D, Hsp27-2D and Hsp27-3D). In these experiments the 13+ dimer was
selected to minimize overlap from other species, and IM spectra was acquired under the
conditions stated above. A power-calculation used to determine an appropriate charge state
for CIU analysis (which is dependent on the molecular mass)34 indicated that the 13+ charge
state is suitable for investigating the CIU of Hsp27 dimers (power-calculation gave the
optimal charge state as 12+). The trap and transfer collision energy was increased in 5 V
increments from 15 – 60 V. IM heat maps and CIU difference plots were generated using
CIUsuite with default settings35. To determine the relative proportion of unfolded dimer
with increasing activation energy, IM chromatograms at each activation energy increment
were measured and normalised to the highest intensity. The relative abundance of unfolded
dimer was determined by the intensity of any unfolded species present (i.e. any observed
intensity that is not attributed to the folded dimer).
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Results
Using bulk measurement techniques to identify changes in Hsp27 tertiary and quaternary
structure with serine substitutions that mimic phosphorylation. The increased abundance
of Hsp27 dimers with MMP strongly correlates with enhanced chaperone activity23. To
determine whether other changes occur to the tertiary and quaternary structure of Hsp27
upon introduction of MMP, biophysical studies were conducted on these isoforms. Intrinsic
tryptophan fluorescence studies revealed that all Hsp27M isoforms (i.e. those containing
one, two or three MMP) had an enhanced tryptophan fluorescence intensity compared to
Hsp27 wild-type (WT), consistent with increased solvent exposure of one or more
tryptophan residues (Hsp27 has six tryptophan residues; W16, W22, W42, W45, W51 and
W95) (Figure 1A-B). However, this was not accompanied by a shift in the maximum emission
wavelength (Figure 1A-B). Analytical-size exclusion chromatography (SEC) of Hsp27M in
ammonium acetate (NH4OAc) (i.e. the buffer used for all the MS experiments), in general
mirrors the results obtained when phosphate buffer was used23. An increase in the number
of MMP reduces the size of Hsp27 oligomers (Figure 1C-D); which was observed previously
when the samples were analysed in phosphate buffer23. Single Hsp27M isoforms eluted in
two distinct peaks, one with an elution volume similar to that of Hsp27-WT (~590 kDa) and a
relatively small proportion that eluted in a peak corresponding to a molecular mass of
~45 kDa (Figure 1C). The proportion of the ~45 kDa species, relative to the large 590 kDa
species, increased significantly for the double Hsp27M isoforms (Figure 1D). Hsp27-S78/82D
exhibited the largest proportion of smaller oligomers (45 – 158 kDa) across all the double
Hsp27M isoforms studied. The triple phosphomimic (Hsp27-S15/78/82D; Hsp27-3D) eluted
as a single species ~45 kDa, corresponding to the mass of a dimer (Figure 1C-D). A potential
reason for the variation in elution profiles compared to our previous work23 could be due to
the differences in the buffer systems (phosphate buffer with a pH of 7.4 was used previously
whereas this work was conducted in the MS-compatible buffer ammonium acetate and a pH
of 6.8 to replicate that used in the MS experiments). Other studies have shown that small
differences in pH can cause significant differences in quaternary dynamics of sHsps36, while
the sensitivity of sHsps to buffer composition has also been noted37,38 . However, both sets
of data are clearly consistent with an increase in the dissociation of Hsp27 oligomers into
dimers with increasing MMP.
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Figure 1: Intrinsic tryptophan fluorescence and analytical size-exclusion chromatography
of Hsp27M. A-B: Intrinsic tryptophan fluorescence of single Hsp27M (A) and double Hsp27M
(B) isoforms (50 µM) in 200 mM ammonium acetate (NH4OAc) buffer (pH 6.8) showing an
increase in tryptophan exposure relative to Hsp27-WT. C-D: Analytical-SEC of single Hsp27M
(C) and double Hsp27M (D) (50 µM) in 200 mM NH4OAc (pH 6.8) where successive serine
substitutions enhance oligomer dissociation. Both Hsp27-WT and Hsp27-3D are also
included for relative comparison in these panels. Elution volume of molecular weight
standards are indicated above the chromatograms (in kDa).

Hsp27-3D and Hsp27-WT undergo subunit exchange. In order to elucidate whether
phosphorylated dimers of Hsp27 (Hsp27-S15/78/82D: Hsp27-3D) could be incorporated into
oligomers of non-phosphorylated Hsp27 (Hsp27-WT), we performed a bulk-FRET assay to
monitor subunit exchange between these two isoforms. It was observed that Hsp27-3D was
capable of subunit exchange with Hsp27-WT, and the rate of exchange (0.2740 ± 0.02 min-1)
was faster than that of WT homo-oligomers (0.2289 ± 0.01 min-1) (Figure 2A). To confirm
that Hsp27-3D was incorporated into large oligomers formed by Hsp27-WT, samples from
the bulk-FRET experiments were collected and analysed by analytical-SEC with multiwavelength detection. Analytical-SEC showed that the mixed sample of Hsp27-WT and -3D
9

resulted in a peak eluting from the column at an elution volume typical of large Hsp27
oligomers (~8 mL), and that this peak contained both Hsp27 isoforms (Figure 2B-C).

Figure 2: Hsp27-WT and Hsp27-3D are capable of undergoing subunit exchange. A: BulkFRET assays indicating that subunit-exchange of Hsp27-WT with Hsp27-3D occurs at a rate
faster than WT exchange (left panel). Subunit exchange was performed at 37 °C at a 1:1
molar ratio (25 µM total protein concentration) in 50 mM phosphate buffer (pH 7.4). The
emission fluorescence from Alexa labels was used as a measure of subunit exchange. A
general schematic of subunit exchange between homo- and hetero-oligomeric forms are as
indicated (right panel). Bulk-FRET data is the mean ratio in fluorescence intensity ± standard
error of the mean of three independent experiments. B: Analytical-SEC of Hsp27-WT
(CF488) with Hsp27-WT (CF647) after bulk-FRET subunit exchange C: Analytical-SEC of
Hsp27-3D (CF488) with Hsp27-WT (CF647) after bulk-FRET subunit exchange. Both B and C
were at a 1:1 molar ratio (25 µM total protein concentration) in 50 mM phosphate buffer
(pH 7.4). Absorbance of Hsp27-WT and Hsp27-3D was measured at multiple wavelengths
(280 nm: black; 495 nm: green; 650 nm: red).
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Increased serine substitutions alter the conformation and unfolding dynamics of Hsp27
dimers. Characterising the secondary, tertiary and quaternary structure of partially
disordered proteins using bulk-averaged methods only provides relatively low-resolution
structural information which is unable to discriminate between individual oligomeric states.
As a result, alternate approaches are required to probe the structure of these assemblies
with greater resolution. IM-MS is an extremely useful tool to analyse the size, shape and
conformation of folded proteins in various states (e.g. unfolded/folded)39. By isolating a
particular species of interest, in this case the dimer13+ (~3,510 m/z) and the 12mer31+
(~8,800 m/z), both corresponding to unique mass to charge ratios (i.e. this charge-state
peak does not overlap with charges states of other populated stoichiometries), differences
in these oligomeric forms (in terms of shape and conformation), with increasing numbers of
MMP, can be probed (Figure 3A). In addition, as IM-MS is sensitive to the folding states of
proteins, it also enables the unfolding of proteins in the gas-phase to be observed. During
IM-MS, an increase in activation energy leads to CIU, which can be observed as an increase
in arrival time40. Thus, the unfolding process can be visualised to determine distinct
conformations through which a protein may transition (i.e. native, compaction,
intermediately folded and unfolded), as well as the relative stability of a species as a
function of activation energy.
We sought to compare the arrival time distribution (ATD) of the Hsp27 dimer13+ with
successive MMPs at a set height (WH) under low activation energy and gentle source
conditions (i.e. native-like state; Figure 3B-C). Hsp27-WT was not able to be included in this
analysis as the proportion of free dimer in solution at the concentrations required for this
experiment (50 µM; monomeric concentration) was too low to be detected under the
instrument settings used in these experiments. In addition, all the single Hsp27M isoforms
have been shown to be structurally and functionally similar (as were all the double Hsp27M
isoforms)23, and thus the S15D, S15/82D and S15/78/82D mutants were selected as
representatives of the 1D, 2D and 3D isoforms respectively. The data from these Hsp27M
isoforms demonstrates that the tertiary structure of Hsp27 dimers changes with successive
MMP. The dimer ATD was observed to broaden with an increasing number of MMP (Figure
3B; inset) (Table S1). These data are consistent with increased heterogeneity in the
ensemble of states able to be accessed by Hsp27 dimers with MMP. In contrast, there was

11

no distinct shift in either the centroid of breadth of the ATD observed for the 12mer31+
between the Hsp27M and Hsp27-WT isoforms (Figure 3C; inset). This is consistent with the
N-terminal region of Hsp27 being on inside of the 12mers, such that the tertiary structural
changes we observed in the dimer do not impact the overall collision cross-section of the
oligomer. Hsp27-3D was not able to be used in this latter experiment as we have previously
shown that it is predominantly dimeric23. Overall, the data demonstrates that MMP alter the
tertiary structure of Hsp27 dimers, making them more heterogeneous (and by inference,
flexible) with successive MMP.
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Figure 3: Arrival time distribution analysis and collision-induced unfolding trajectories of
Hsp27 using ion mobility – mass spectrometry. A: Native MS of Hsp27-S15D under low
activation energy (15 V), demonstrating the approach used to observe the conformation
and unfolding dynamics of Hsp27 dimers. The 13+ charge state of dimers (3,510 m/z; red
box) and the 31+ charge state of the 12mer (8,800 m/z, blue box) were selected for analysis.
B: ATD analysis of Hsp27M dimers13+ at low activation energy (15 V) and a range of wave
heights (WH in V) showing that the structure of the dimer is more heterogenous (broadness
of the peak; inset) with an increasing number of MMP. C: ATD analysis of Hsp27-WT and
Hsp27M 12mers31+ at low activation energy (15 V) and two WHs which shows that the arrival
time and broadness of the peak (and hence conformation; inset) of the 12mer does not vary
significantly with increasing numbers of MMP.

To probe potential differences in the structure of Hsp27M dimers further, IM-MS was used
to monitor the unfolding of these dimers at different WHs by means of CIU. By increasing
the acceleration into the collision cell of the mass spectrometer, whilst maintaining low
activation energy in the source, the unfolding of Hsp27 dimers was monitored (Figure 4).
Across all isoforms, it appears that both monomeric units within the (disulfide-bonded)
dimer unfold simultaneously, i.e. there is no evidence of one monomer unfolding prior to
the other as only a single conformation/species is observed after 40 V (two unfolding events
would be observed with increasing activation energy if one monomer unfolded prior to the
other) (Figure 4B, S1A, S1D). In addition, a slight compaction of the dimer (evidenced by a
decrease in the ATD) was evident for the Hsp27-2D and Hsp27-3D isoforms at 30 V and WH8
(Figure 4B, 4D), WH9 (Figure S1B) and WH10 (Figure S1D-E), prior to unfolding. However,
the amount of activation energy required to unfold the dimer increases when the third
MMP is present, such that Hsp27-3D is the most resistant to unfolding of all the Hsp27
isoforms (45 V at WH8 and WH9, compared to 40 V for Hsp27-1D and 2D at these wave
heights) (Figure 4B, S1A, S1C, S1F).
To determine the differences in the CIU of Hsp27 dimers, pair-wise comparisons of Hsp27M
isoforms (i.e. Hsp27-1D versus -2D and Hsp27-1D versus -3D etc.) were generated. These
enabled quantitative differences in the ATD of the unfolding dimer with increasing
activation energy to be measured (Figure 4D, S1B, S1D). Interestingly, the folded and
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unfolded states of Hsp27-3D differ when compared to Hsp27-1D and -2D across multiple
wave heights; more activation energy is required for the unfolding of the Hsp27-3D dimer
compared to the Hsp27-1D or -2D dimers (Figure 4D, S1B, S1D). The unfolding trajectories of
Hsp27-1D and Hsp27-2D, compared to Hsp27-3D, at WH8 resulted in a RMSDs of 11.34 %
and 9.69 %, respectively (the RMSD of independent trajectories of the same protein was
5.44 %; see Figure S2). This indicates that the unfolding pathway of Hsp27-3D differs
substantially to that of Hsp27-1D and Hsp27-2D. Overall, these data suggest that the
negative charges introduced by MMPs are involved in electrostatic interactions within
Hsp27 dimers, resulting in the dimer being more resistant to unfolding. In addition, the data
also demonstrates that IM-MS is a sensitive technique to detect such electrostatic
interactions within heterogeneous proteins.
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Figure 4: Observing the collision-induced unfolding of Hsp27M dimers by IM-MS. A: The
various conformations that Hsp27 dimers adopt in the gas-phase at low activation energy.
The increase in activation (collision) energy results in a slight compaction of dimers, which
then unfold with further increases in activation energy. The unfolding intermediates can be
observed prior to complete unfolding of the dimer (a generic collision-induced unfolding,
CIU, pathway is illustrated above the heat map). B: The CIU of the Hsp27M dimer13+
(monitored via changes in the arrival time of species in the IM chamber) was examined with
increasing activation energy (V). The heat maps indicate that no distinct intermediate
15

species between folded and unfolded states are present as the dimer unfolds in the gasphase as a function of activation energy at the same wave height (WH in V) (WH8). Across
all wave heights, only a single unfolding transition is observed (white dashed line),
suggesting that both monomers (which are disulfide-linked via Cys137) unfold
simultaneously in the gas-phase. C: The abundance of unfolded dimer (y-axis) was
determined by tracking the loss of folded dimer with increased activation energy at a set
wave height (WH8). The Hsp27-3D dimer appears to be more stable (i.e. requires increased
activation energy to reach 50% unfolded) compared to the –1D and -2D isoforms. D: Heat
maps generated by using the CIUsuite compare function which highlight the differences in
the unfolding of the dimer13+ in the gas-phase between two isoforms at the same wave
height (WH8). Difference plots are shown whereby features that identify most strongly with
one fingerprint are shown on a red intensity scale and the other on a blue intensity scale.
RMSDs (%) (bottom right corner) indicate the difference in the unfolding of the dimer
between each pair analysed. Hsp27-1D vs Hsp27-2D (top), Hsp27-1D vs Hsp27-3D (middle)
and Hsp27-2D vs Hsp27-3D (bottom) are shown. The greatest difference in the unfolding
dynamics was observed when Hsp27-1D or Hsp27-2D were compared with Hsp27-3D.
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Discussion
The role of Hsp27 in intracellular proteostasis is inherently linked to its structural dynamics,
whereby changes in structure at the tertiary and quaternary level modulate its chaperone
activity. We have previously utilised MMP to investigate the site-specific role
phosphorylation has on the structure and chaperone function of Hsp27, reporting that
increased levels of phosphorylation induce oligomer dissociation into dimers which
correlates to enhanced chaperone activity23. The work presented here aimed to define the
conformation and dynamics of Hsp27 oligomers, in particular, chaperone-active dimers.
Many biophysical approaches, such as intrinsic tryptophan fluorescence and analytical-SEC
used here, only provide low-resolution structural information on proteins, which is limited
when dealing with large heterogeneous assemblies such as the sHsps. Whilst we observed
enhanced tryptophan exposure with MMP compared to WT (Figure 1A-B), our analytical-SEC
data indicates that there is an increased abundance of smaller Hsp27 isoforms with MMP.
As it is not possible to discern between individual oligomeric species with these ensembleaveraging approaches, these changes in tryptophan exposure cannot be attributed to a
particular species. Thus, the increase in tryptophan fluorescence intensity with MMP may
reflect either an increase in the proportion of dissociated species that arise due to these
mutations (i.e. changes in quaternary structure) or changes in the environment of the
tryptophan residues in the oligomers themselves (i.e. changes in tertiary structure).
Interestingly, as there was no accompanying shift in the maximum emission wavelength
upon MMP, fluorescence quenching may be responsible for the lower tryptophan
fluorescence observed for Hsp27-WT. Of note, five of the six tryptophan residues in Hsp27
reside in the N-terminal domain, and one (W16) is immediately adjacent to S15, a site of
phosphorylation in Hsp27 and modified by MMP in this work. Thus, the MMP may result in a
decrease in localised quenching of tryptophan fluorescence leading to the increase in
tryptophan fluorescence observed for all Hsp27M isoforms. However, other mechanisms
that lead to a change in the quantum yield of tryptophan fluorescence are possible41. Due to
the limitations present in using low resolution approaches to probe the structure and
dynamics of Hsp27, we chose to use IM-MS which enables individual oligomeric species to
be analysed within a complex mixture.
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The overall findings of this work demonstrate that there are distinct differences in the
structure of Hsp27 dimers as a result of MMP, whereby with an increasing number of MMP
the Hsp27 dimer becomes more heterogeneous. Our data also suggest that the negative
charges introduced by phosphorylation are involved in electrostatic interactions within the
dimer, which would likely lead to an increase in stability of the dimer in solution. We
conclude that these structural changes to the dimer upon phosphorylation likely contribute
to enhanced chaperone activity23 through increasing its capacity to interact with misfolded
client proteins to attenuate aggregation.
As it was previously shown that MMP enhance oligomer dissociation of Hsp27, it was
postulated that oligomeric disassembly is mediated by negative charge repulsion between
dimers that result from phosphorylation23. We therefore tested whether Hsp27-3D was
capable of being incorporated into large Hsp27-WT oligomers since the negative charge
introduced to mimic phosphorylation in Hsp27-3D could prevent this from occurring. BulkFRET and SEC analysis demonstrated that Hsp27-3D is indeed capable of being incorporated
into large Hsp27-WT oligomers3. This finding indicates that Hsp27 oligomers are able to
accommodate negative charges introduced by phosphorylation, at least up to a point. We
reason that there is a threshold at which the associative forces that hold the oligomer
together are outweighed by the Coulombic repulsion caused by incorporation of increasing
numbers of phosphate groups, eventually leading to dissociation of the Hsp27 oligomers,
and that these factors contribute to the faster subunit exchange of Hsp27-3D. Whilst studies
of αB-c using MMP have demonstrated that variant isoforms are also capable of subunitexchange37,42, phosphorylation of αB-c does not lead to the complete dissociation of
oligomers (in contrast to Hsp27). Rather, the rate of subunit-exchange between αB-c
oligomers increases substantially with MMP37. Thus, for both Hsp27 and αB-c, the
population of dissociated species at any point in time is increased upon the introduction of
MMP (and by inference phosphorylation), such that more chaperone-active units are
available to interact with and prevent the aggregation of client proteins.
The ability to observe specific Hsp27 oligomeric forms by using native MS allowed us to
interrogate how the conformation of the full-length dimer varies due to MMP. By comparing
the ATD of Hsp27 dimers between Hsp27M forms under identical IM-MS conditions, we
conclude that MMP result in the broadening of the ATD peak width of the dimer and an
18

increase in the arrival time at some WHs. We did not detect any change in the shape or
stability of the 12mer oligomer with MMP by IM-MS. Together these results suggest that, at
the level of the dimeric building block, progressive serine phosphorylation of Hsp27 leads to
increasing oligomeric dissociation. It also results in the dimer being able to access more
conformations (i.e. being more flexible) with MMP.
Interestingly, the unfolding pathway (and by inference stability) of the Hsp27 dimer differed
with an increase in the number of MMP, such that more energy was needed to unfold the
Hsp27-3D dimer compared to the Hsp27-1D or -2D dimer. The likely explanation for this is
that the negative charges introduced by phosphorylation (or in our case Asp residues to
mimic phosphorylation) are involved in intra-dimer electrostatic interactions, making the
dimer more resistant to unfolding in the gas phase, where these electrostatic interactions
are strengthened43,44). Nevertheless, we reason these interactions must still originate in
solution, and note that similar interactions have also been previously observed for another
mammalian sHsp, Hsp2045. As such, we contend that our data demonstrates that IM-MS
acts as a sensitive diagnostic means for detecting such interactions which are difficult to
study in solution.
In summary, these data indicate that phosphorylation of Hsp27 results in changes to the
tertiary structure of Hsp27 dimers, such that the dimer adopts more conformations (i.e. an
increasingly heterogeneous dimer) and that the N-terminal domain forms strong intra-dimer
electrostatic interactions in solution. We postulate that these new intra-dimer interactions
act to weaken the inter-dimer interactions, thereby precipitating disassembly of the
oligomers. As a result, these changes lead to an enhanced ability of phosphorylated Hsp27
dimers to recognise and interact with misfolded and aggregating proteins. In summary,
phosphorylation of Hsp27 result in structural changes at the tertiary and quaternary level,
and these facilitate changes in Hsp27 chaperone activity in cells. In addition, the data also
demonstrates the ability of IM-MS to probe the structure and dynamics of heterogeneous
proteins, one stoichiometry at a time.
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Supplemental Tables and Figures

Figure S-1: Observing the differences in collision-induced unfolding dynamics of Hsp27M
dimers by IM-MS at various wave heights. Related to Figure 4. A, D: The CIU of the Hsp27M
dimer13+ (monitored via changes in the arrival time of species in the IM chamber) was
examined with increasing activation energy (V). The heat maps indicate that no distinct
intermediate species (i.e. no partially structured intermediate) between folded and
unfolded states are present as the dimer unfolds in the gas-phase as a function of activation
energy at various wave heights (WH: 9 V and 10 V). Across all wave heights, only a single
unfolding transition is observed (white dashed line), indicating that both monomers (which
are disulfide-linked via Cys137) unfold simultaneously in the gas-phase. B, E: Heat maps
highlight the differences in the unfolding of the dimer13+ in the gas-phase between two
isoforms at various wave heights (WH: 9 V and 10 V). RMSD values (%) (bottom right corner)
indicate the difference in the unfolding of the dimer between each pair analysed (pairs
24

analysed stated above in heat map scale where greatest difference attributed to one
isoform indicated by either dark blue or red). The greatest difference in the unfolding
dynamics was observed when Hsp27-1D and -2D were compared with Hsp27-3D. C, F: The
abundance of unfolded dimer (y-axis) was determined by tracking the loss of folded dimer
with increased activation energy at various wave heights (WH: 9 V and 10 V). The Hsp27-3D
dimer appears to be more stable (i.e. requires increased activation energy to reach 50%
unfolded) compared to the –1D and -2D isoforms. CIU difference plots and RMSD values
were calculated using CIUsuite with default settings 35.

Figure S-2: Internal RMSD determination of the collision-induced unfolding dynamics of
Hsp27M dimers by IM-MS. Related to Figure 4. CIU of Hsp27M dimers was monitored with
increasing activation energy. Heat map highlights the differences in the unfolding of the
dimer13+ in the gas-phase between the same isoform (Hsp27-S15D; Hsp27-1D) calculated on
two different occasions at the same WH (V). RMSD value (%) (bottom right corner) indicates
the difference in the unfolding of the dimer between the pair analysed (pairs analysed
where greatest difference attributed to one isoform indicated by either dark blue or red).

Table S-1: Arrival time analysis of Hsp27 dimers and 12mers by IM-MS. Related to Figure
3. Arrival time and peak width at half height of Hsp27M dimers and 12mers as determined
by IM-MS. The increase in both arrival time and peak width at half height is indicative of an
increase in the unstructured state of the species of Hsp27M.

Dimer13+
Hsp27-1D
Hsp27-2D
Hsp27-3D
12mer31+
Hsp27-WT
Hsp27-1D

Arrival time (ms)
WH8
WH9
WH10
9.87
7.31
5.9
10.13
7.42
5.52
10.39
7.38
5.9
Arrival time (ms)
WH11.5
WH13
13.07
9.23
12.81
9.22

Peak width at half height (ms)
WH8
WH9
WH10
1.68
1.42
0.92
1.52
1.55
1.22
1.8
2.18
1.76
Peak width at half height (ms)
WH11.5
WH13
2.1
1.17
2.0
1.22
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Hsp27-2D

12.81

9.22

2.0

1.29
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